Mohapatra Sonmoon, Krishna Somashekar G, Pannala Rahul
Department of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ 85259, USA.
Department of Gastroenterology and Hepatology and Nutrition, The Ohio State Wexner Medical Center, Columbus, OH 43210, USA.
Diagnostics (Basel). 2023 Feb 16;13(4):749. doi: 10.3390/diagnostics13040749.
A combination of several factors, including the increasing use of cross-sectional imaging and an aging population, has led to pancreatic cystic lesions (PCLs) becoming the most detected incidental pancreatic lesions. Accurate diagnosis and risk stratification of PCLs is challenging. In the last decade, several evidence-based guidelines have been published addressing the diagnosis and management of PCLs. However, these guidelines cover different subsets of patients with PCLs and offer varying recommendations regarding diagnostic assessment, surveillance, and surgical resection. Further, recent studies comparing the accuracy of various guidelines have reported significant variations in the rate of missed cancer versus unnecessary surgical resections. In clinical practice, it is challenging to decide which guideline to follow specifically. This article reviews the varying recommendations of the major guidelines and results of comparative studies, provides an overview of newer modalities not included in the guidelines, and offers perspectives on translating the guidelines into clinical practice.
包括横断面成像的使用增加和人口老龄化在内的多种因素共同作用,导致胰腺囊性病变(PCL)成为最常被检测到的胰腺偶发病变。PCL的准确诊断和风险分层具有挑战性。在过去十年中,已经发布了几项基于证据的指南,涉及PCL的诊断和管理。然而,这些指南涵盖了不同的PCL患者亚组,并在诊断评估、监测和手术切除方面提供了不同的建议。此外,最近比较各种指南准确性的研究报告了漏诊癌症率与不必要手术切除率之间存在显著差异。在临床实践中,决定具体遵循哪项指南具有挑战性。本文回顾了主要指南的不同建议和比较研究结果,概述了指南中未包括的较新方法,并就将指南转化为临床实践提供了观点。